The company's AI-focused roadmap necessitates the construction of a substantial computing infrastructure, which will include 350,000 H100 graphics cards from Nvidia by the end of 2024.
ThermoGenesis Holdings, Inc. (NASDAQ:THMO) (the "Company"), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced the pricing of its public offering of